Clinical pharmacology of cephalexin administered by intravenous injection
Open Access
- 1 June 1972
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 25 (6) , 518-520
- https://doi.org/10.1136/jcp.25.6.518
Abstract
Cephalexin IG was given by intravenous injection to eight normal volunteers, five patients with chronic renal failure, and three patients during a period of haemodialysis. In normal subjects there was a rapid fall in serum concentration and 80% of the administered dose was excreted in the urine within two hours. The mean serum half life was 1·1 hours (range 0·6-1·8 hours). Prior treatment with probenecid in two subjects led to a twofold increase in serum concentration two hours after injection. In the patients with chronic renal failure antimicrobial activity persisted for 24 hours and the half life ranged from 6·1 to 18·1 hours. Haemodialysis led to partial removal of cephalexin from the blood, but antimicrobial activity remained eight hours after injection at the end of the dialysis period. The serum half life in these patients was 5·1, 5·6, and 5·7 hours.Keywords
This publication has 9 references indexed in Scilit:
- Oral Cephalexin and Ampicillin: Antimicrobial Activity, Recovery in Urine, and Persistence in Blood of Uremic PatientsAnnals of Internal Medicine, 1970
- Cephalexin Therapy as Related to Renal FunctionThe Lancet Healthy Longevity, 1970
- Clinical pharmacology of cephalexin administered intravenously.1970
- Cephalexin: human studies of absorption and excretion of a new cephalosporin antibioticBritish Journal of Pharmacology, 1969
- DemethylchlortetracyclineNew England Journal of Medicine, 1958